Cited 0 time in
Half-life of Apixaban During Massive Apixaban Overdose
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sohn, Ju-Tae | - |
| dc.date.accessioned | 2023-09-22T02:43:26Z | - |
| dc.date.available | 2023-09-22T02:43:26Z | - |
| dc.date.issued | 2024-06 | - |
| dc.identifier.issn | 0897-1900 | - |
| dc.identifier.issn | 1531-1937 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/67971 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.format.extent | 2 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | SAGE Publications | - |
| dc.title | Half-life of Apixaban During Massive Apixaban Overdose | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1177/08971900231199672 | - |
| dc.identifier.scopusid | 2-s2.0-85169905881 | - |
| dc.identifier.wosid | 001065245100001 | - |
| dc.identifier.bibliographicCitation | Journal of Pharmacy Practice, v.37, no.3, pp 535 - 536 | - |
| dc.citation.title | Journal of Pharmacy Practice | - |
| dc.citation.volume | 37 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 535 | - |
| dc.citation.endPage | 536 | - |
| dc.type.docType | Letter | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordAuthor | apixaban | - |
| dc.subject.keywordAuthor | half-life | - |
| dc.subject.keywordAuthor | overdose | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
